CareDx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
CareDx, Inc. (NASDAQ:CDNA) – The Transplant Company — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare
BusinesswireApr 19 16:05 ET
CareDx (CDNA) Moves 5.5% Higher: Will This Strength Last?
Yahoo FinanceApr 18 03:47 ET
CareDx Price Target Maintained With a $15.00/Share by Stephens & Co.
CareDx Price Target Maintained With a $15.00/Share by Stephens & Co.
Dow JonesApr 17 10:21 ET
Express News | Stephens & Co. Reiterates Overweight on CareDx, Maintains $15 Price Target
Moomoo 24/7Apr 17 10:11 ET
CareDx Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/17/2024 85.64% Stephens & Co. → $15 Reiterates Overweight → Overweight 11/09/2023 23.76% Stephens & Co.
BenzingaApr 17 10:06 ET
Express News | CareDx Appoints John W. Hanna As Its New President And CEO, And Member Of Board Of Directors, Effective April 15, 2024
Moomoo 24/7Apr 16 16:03 ET
CareDx: Hanna Named to Board of Directors>CDNA
CareDx: Hanna Named to Board of Directors>CDNA
Dow JonesApr 16 16:03 ET
CareDx: Hanna Appointments Effective April 15 >CDNA
CareDx: Hanna Appointments Effective April 15 >CDNA
Dow JonesApr 16 16:03 ET
Express News | CareDx- Appointed John W. Hanna as Its New President and CEO, Effective April 15, 2024
Moomoo 24/7Apr 16 16:02 ET
Express News | CareDx Appoints John W. Hanna as Its New President and Chief Executive Officer
Moomoo 24/7Apr 16 16:02 ET
Shareholders in CareDx (NASDAQ:CDNA) Have Lost 89%, as Stock Drops 11% This Past Week
It's not possible to invest over long periods without making some bad investments. But you want to avoid the really big losses like the plague. So consider, for a moment, the misfortune of CareDx, I
Simply Wall StApr 13 10:28 ET
CareDx and Collaborators Present Latest Cardiothoracic Advancements at the 2024 International Society for Heart and Lung Transplantation Meeting
Late-Breaking Abstract Presentation to Showcase Results from SHORE Registry Highlighting Benefits of Surveillance with HeartCareBRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA)- The Tran
BusinesswireApr 9 07:00 ET
CareDx Appoints Bryan Riggsbee to Its Board of Directors
CareDx, Inc. (NASDAQ:CDNA) — The Transplant Company — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare
BusinesswireMar 11 16:10 ET
CareDx Hold Rating: Balancing Modest Growth Prospects With Operational Uncertainties
TipRanksMar 6 06:25 ET
Earnings Call Summary | CareDx(CDNA.US) Q4 2023 Earnings Conference
The following is a summary of the CareDx, Inc. (CDNA) Q4 2023 Earnings Call Transcript:Financial Performance:CareDx reported a full-year '23 revenue of $280.3 million, surpassing its updated guidance.
moomoo AIFeb 29 11:14 ET · Conference Call
CareDx, Inc (NASDAQ:CDNA) Q4 2023 Earnings Call Transcript
Yahoo FinanceFeb 29 10:43 ET
Balancing Growth Prospects Against Financial Challenges: A Hold Rating for CareDx
TipRanksFeb 29 06:44 ET
CareDx Unveils Updated Financial Health and Strategy Presentation
TipRanksFeb 28 16:49 ET
Express News | CareDx Expects 2024 Revenue Of $260M-$274M, Est $260.618M
Moomoo 24/7Feb 28 16:36 ET
Recap: CareDx Q4 Earnings
CareDx (NASDAQ:CDNA) reported its Q4 earnings results on Wednesday, February 28, 2024 at 04:05 PM.Here's what investors need to know about the announcement.EarningsCareDx beat estimated earnings by 37
BenzingaFeb 28 16:15 ET
No Data
No Data